Akorn is a pharmaceutical company that specializes in the development, manufacturing, and marketing of generic and branded prescription drugs. The company offers a wide range of products across various therapeutic areas.
In 1971, Akorn was established as a research and development company.
In 1983, Akorn entered the generic drug market.
In 1993, Akorn expanded its product portfolio through acquisitions.
In 2004, Akorn started marketing branded prescription drugs.
In 2019, Akorn was acquired by Fresenius Kabi, a subsidiary of Fresenius SE & Co. KGaA.
Teva Pharmaceuticals is a global pharmaceutical company that produces both generic and branded drugs. They operate in multiple therapeutic areas and have a wide product portfolio.
Mylan is a leading pharmaceutical company known for its generic drugs. They offer products in various therapeutic areas and have a focus on affordable healthcare.
Sandoz is a subsidiary of Novartis and is one of the largest pharmaceutical companies focusing on generics. They have a diverse product portfolio and operate globally.
Akorn manufactures a wide range of generic drugs to provide affordable treatment options across various therapeutic areas.
Akorn markets branded prescription drugs that address specific medical needs and offer innovative treatment options.
Akorn develops and manufactures specialty pharmaceuticals that cater to niche markets or complex medical conditions.
Akorn offers ophthalmic pharmaceuticals, including eye drops and ointments, for the treatment of eye conditions and diseases.
Akorn produces injectable drugs used in hospitals and clinics for various treatments, such as anesthesia, pain management, and critical care.
Akorn specializes in the development, manufacturing, and marketing of generic and branded prescription drugs.
Akorn is owned by Fresenius Kabi, a subsidiary of Fresenius SE & Co. KGaA.
Akorn is headquartered in Lake Forest, Illinois, United States.
Akorn's products cover a wide range of therapeutic areas, including ophthalmology, anesthesia, pain management, critical care, and more.
Akorn is committed to providing affordable treatment options through its generic drug offerings.
